Search

Search Constraints

You searched for: Author/Creator Blits, Bas

Search Results

1. L4 Sustained and strong HTT silencing by AAV5-miHTT as therapy for huntington's disease. (13th September 2016)

2. L5 Pre-clinical evaluation of aav5-mihtt gene therapy of huntington's disease in rodents. (13th September 2016)

3. I04 AAV5-MIHTT gene therapy demonstrates broad distribution and strong human mutant huntingtin lowering in a huntington disease minipig model. (September 2018)

4. I05 Sustained mutant huntingtin lowering in the brain and cerebrospinal fluid of huntington disease minipigs mediated by AAV5-MIHTT gene therapy. (September 2018)

5. AAV mediated gene therapy as local treatment modality directed against amyloid beta oligomers in the brain using a high affinity, high specificity antibody: Nonhuman: Preclinical immunotherapeutic studies. (7th December 2020)